Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5F9M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,818
Award facts
- Contract value 100% obligated
- $18,818.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $18,818.07 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) Unready 300 mg pens in 2 ml formulations. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 28, 2026, issued on January 27, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain.
This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This primary IDC vehicle enables the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs globally. The contract reflects DLA's strategic approach to pharmaceutical procurement through prime vendor arrangements designed to efficiently fulfill essential medical supply needs across military treatment facilities and other federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F5F9M?
SPE2DR26F5F9M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F5F9M worth?
The government has obligated $18,818 on SPE2DR26F5F9M.
Is contract SPE2DR26F5F9M an order under another contract?
Yes. SPE2DR26F5F9M is a delivery order under SPE2DR25D3306, an indefinite delivery contract.
Was contract SPE2DR26F5F9M competed?
The extent of competition for SPE2DR26F5F9M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award